Determination of fexofenadine in Hank's balanced salt solution by high‐performance liquid chromatography with ultraviolet detection: application to Caco‐2 cell permeability studies

The drug‐transporting proteins can affect the pharmacokinetics and pharmacodymanics of many drugs, resulting in an erratic and unpredictable pharmacological response. The Caco‐2 monolayer is routinely applied to investigate the carrier‐mediated transport of drugs. Therefore, the selection of a marker compound able to characterize the activity of such transporters is crucial. Fexofenadine (FEX), a P‐gp/OATP substrate, can be considered a suitable probe. However, in order to use be used as a marker compound, it is mandatory to develop an analytical method able to quantify this drug during the in vitro permeability assay. An HPLC method with ultraviolet detection was developed; the mobile phase consisted of phosphate buffer (pH 3.2) containing 10 m m of sodium octanosulphonate and acetonitrile (60:40) and the flow rate was set at 1.2 mL/min. Fexofenadine was eluted at 40°C, the retention time was about 4.6 min. The LOD and LOQ values were 1.9 and 6.2 ng/mL, respectively. Verapamil and ketoconazole, the most common P‐gp inhibitors, were eluted as distinct peaks of that corresponding to fexofenadine The method was successfully applied to quantify the amount of FEX transported across the Caco‐2 monolayer and could be an additional tool for those investigating the role of membrane transporters on drug absorption. Copyright © 2014 John Wiley & Sons, Ltd.     

Dipolar and V-shaped structures incorporating methylenepyran and diazine fragments

Thirteen novel dipolar and V-shaped chromophores with pyranylidene electron-donating part, diazine electron-withdrawing part and various π-linkers were synthesized. The extent of intramolecular charge transfer, structure-property relationships and optical properties were further investigated by UV/Vis absorption, electrochemistry, and DFT calculations.     

Study of aerodynamic and release properties of inhaled particles containing cyclodextrins

The aim of this study was to investigate the influence of different cyclodextrins (CyD) on physical characteristics of inhalation dry powders. The particle size was characterised by Aerosizer^® LD and aerodynamic behaviour of inhaled complexes assessed by twin-stage liquid impinger. The in vitro release profile of the powders was studied through Franz cell modified method. Produced particles showed a suitable size for pulmonary delivery, ranging between 1 and 5 μm. The nature of the CyD affected the powders performance on reaching the lower compartment (“Lungs”), mainly by the altering their aerodynamic properties, which is reflected on the different percentages of their emitted respirable fractions. HP-γ-CyD:fluticasone propionate complex showed a fast release of corticosteroid while γ-CyD had a constant release throughout time. The best characteristics for pulmonary delivery were obtained with acetyl-γ-CyD:fluticasone propionate complex.     

Optimization of the process variables in the microwave-induced synthesis of carbon xerogels

Carbon xerogels (CX) can be synthesized by microwave-assisted heating. The transfer of this technology to an industrial scale passes through the optimization of the variables that affect the process. The effect of the main operational variables, i.e., initial volume of the precursor, gelation and ageing time and temperature of the synthesis, on the final porous properties of CX has been evaluated. It was found that the development of porosity in the CX synthesised in the microwave oven is hardly influenced by the increase in the initial volume of the precursor solution. This suggests that it is feasible to scale up the production of these materials by means of microwave heating. Furthermore, the consumption of energy does not increase in proportion to the volume of xerogel synthesized. Thus, the process is energy efficient, saves a considerable amount of time and requires only a single device to carry it out. These advantages, along with the fact that a temperature variation of 10 °C is not determinative in the xerogels’ final properties, indicate that CX could be produced on a large scale in a cost effective way .     

Parkia pendula Seed Lectin: Potential Use to Treat Cutaneous Wounds in Healthy and Immunocompromised Mice

Parkia pendula seed lectin was used to treat cutaneous wounds of normal and immunocompromised mice, inducing cicatrization. Methotrexate (0.8 mg/kg/week) was used as immunosuppressive drug. Wounds were produced in the dorsal region (1 cm²) of female albino Swiss mice (Mus musculus), health and immunocompromised. Wounds were daily topically treated with 100 μL of the following solutions: (1) control (NaCl 0.15 M), (2) control Im (0.15 M NaCl), (3) P. pendula seed lectin (100 μg/mL), and (4) P. pendula seed lectin Im (100 μg/mL). Clinical evaluation was performed during 12 days. Biopsies for histopathology analysis and microbiological examinations were carried out in the second, seventh, and 12th days. The presence of edema and hyperemia was observed in all groups during inflammatory period. The first crust was detected from the second day, only in the groups treated with P. pendula seed lectin. Microbiological analysis of wounds from day 0 to day 2 did not show bacterium at P. pendula seed lectin group; however, Staphylococcus sp. was detected every day in the other groups. The lectin markedly induced a total wound closing at P. pendula seed lectin and P. pendula seed lectin Im groups on 11th day of evolution. The present study suggests that P. pendula seed lectin is a biomaterial potential to show pharmacological effect in the repair process of cutaneous wounds.